Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.A5 Laboratories has signed an analytical services contract with BioActif, which owns, markets and distributes pharmaceutical, cosmetics and neutraceutical products throughout Quebec.
Subscribe to our email newsletter
Upon obtaining health Canada laboratory establishment license, A5 Labs will provide a comprehensive analytical and development services for BioActif. The services will include method development, raw materials and finished goods testing as well as stability studies.
Richard Azani, president and CEO of A5 Labs, said: “We are extremely pleased to have reached this agreement with BioActif.
“BioActif’s selection of our services is a terrific endorsement of our capabilities including complex analytical procedures and stability studies, and it is another significant step in establishing A5 Labs as a premium world class CRO and Biotechnology company.”
A5 Labs is a contract research based organisation servicing the pharmaceutical and biotechnology companies in North America. A5 Labs utilises its research capabilities to license and acquire novel biotechnology products for development and commercialisation.